Skip to NavigationSkip to content

China introduces new laws to ensure steady supply of drugs

Published on 17/04/19 at 10:04am

China’s National Health Commission (NHC) has said it will monitor the country’s drugs market more closely in order to ensure a sufficient supply of essential medicines.

Zeng Yixin, vice minister of the NHC, said the commission would increase the supply of bulk drug substance and regulate pricing in an effort to ensure a steady supply.

“Last year we saw the shortage of some medicines but only temporarily or regionally,” Zeng said. “The shortage was mostly caused by the structural imbalance between the supply and demand, the monopoly of certain bulk drug substance or inefficient distribution.”

The move comes after the adoption of a number of policies, intended to ensure the steady supply of medicines, in 2018.

The new measures saw the introduction of a catalogue of medicines in short supply.  Pharmaceutical companies were also required to report which medicines they no longer produce.

The government subsequently cracked down on malpractice in the pharmaceutical market as two firms were fined 12.43 million yuan ($1.85 million) for creating a monopoly on the bulk substance needed for the production of a widely used flu medicine.

Louis Goss

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches